1-[7-[6-(1,2-dihydroxyethyl)-2-pyridinyl]-1-phenyl-3,5-dihydro-2H-1,4-benzodiazepin-4-yl]ethanone
C24H25N3O3 — CID 118255638
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[7-[6-(1,2-dihydroxyethyl)-2-pyridinyl]-1-phenyl-3,5-dihydro-2H-1,4-benzodiazepin-4-yl]ethanone
1-[7-[6-(1,2-dihydroxyethyl)-2-pyridinyl]-1-phenyl-3,5-dihydro-2H-1,4-benzodiazepin-4-yl]ethanone (PubChem CID 118255638) has the molecular formula C24H25N3O3 and a molecular weight of 403.48 g/mol. Its IUPAC name is 1-[7-[6-(1,2-dihydroxyethyl)-2-pyridinyl]-1-phenyl-3,5-dihydro-2H-1,4-benzodiazepin-4-yl]ethanone.
Molecular Properties
| Compound Name | 1-[7-[6-(1,2-dihydroxyethyl)-2-pyridinyl]-1-phenyl-3,5-dihydro-2H-1,4-benzodiazepin-4-yl]ethanone |
|---|---|
| PubChem CID | 118255638 |
| Molecular Formula | C24H25N3O3 |
| Molecular Weight | 403.48 g/mol |
| Exact Mass | 403.19 |
| IUPAC Name | 1-[7-[6-(1,2-dihydroxyethyl)-2-pyridinyl]-1-phenyl-3,5-dihydro-2H-1,4-benzodiazepin-4-yl]ethanone |
| SMILES | CC(=O)N1CCN(c2ccccc2)c2ccc(-c3cccc(C(O)CO)n3)cc2C1 |
| InChI | InChI=1S/C24H25N3O3/c1-17(29)26-12-13-27(20-6-3-2-4-7-20)23-11-10-18(14-19(23)15-26)21-8-5-9-22(25-21)24(30)16-28/h2-11,14,24,28,30H,12-13,15-16H2,1H3 |
| InChIKey | FNZHTVYCUWIKDH-UHFFFAOYSA-N |
| XLogP | 3.27 |
| TPSA | 76.90 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 403.48 |
| LogP ≤ 5 | 3.27 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118255638 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.